Pharma Deals Review, Vol 2010, No 3 (2010)

Font Size:  Small  Medium  Large

Ratiopharm Acquisition Catapults Teva to Lead European Generics Market

PharmaDeals Analyst

Abstract


Teva Pharmaceutical Industries succeeded in finally buying Ratiopharm, Germany’s second largest generics producer from the beleaguered Merckle Group.  The deal, valued at USD 4.95 B, places Teva as the top generics company in Europe.



Add comment

Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.